|
USP31 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.85880000280747E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6822000015182E-08 |
| Normal-vs-Stage2 |
6.695700E-03 |
| Normal-vs-Stage3 |
3.06350000001121E-06 |
| Normal-vs-Stage4 |
5.35179999983093E-07 |
| Stage1-vs-Stage2 |
3.241200E-01 |
| Stage1-vs-Stage3 |
8.377600E-01 |
| Stage1-vs-Stage4 |
7.855600E-01 |
| Stage2-vs-Stage3 |
4.408000E-01 |
| Stage2-vs-Stage4 |
2.520600E-01 |
| Stage3-vs-Stage4 |
6.798000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.65450000553381E-09 |
| Normal-vs-AfricanAmerican |
5.781800E-04 |
| Normal-vs-Asian |
5.658000E-03 |
| Caucasian-vs-AfricanAmerican |
8.699400E-01 |
| Caucasian-vs-Asian |
4.41780000000058E-05 |
| AfricanAmerican-vs-Asian |
2.588100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.1768999986248E-08 |
| Normal-vs-Female |
1.02699999615652E-08 |
| Male-vs-Female |
3.978400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.432100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.30009999935277E-09 |
| Normal-vs-Age(61-80Yrs) |
9.40829999462878E-08 |
| Normal-vs-Age(81-100Yrs) |
4.400400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.767810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.369800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.194000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.338200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.125400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.210000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.622810E-04 |
| Normal-vs-Grade 2 |
3.47040000070464E-08 |
| Normal-vs-Grade 3 |
1.8855999994738E-07 |
| Normal-vs-Grade 4 |
1.84609999998031E-06 |
| Grade 1-vs-Grade 2 |
5.213200E-01 |
| Grade 1-vs-Grade 3 |
3.982200E-01 |
| Grade 1-vs-Grade 4 |
6.383200E-01 |
| Grade 2-vs-Grade 3 |
6.717200E-01 |
| Grade 2-vs-Grade 4 |
6.717600E-01 |
| Grade 3-vs-Grade 4 |
4.461800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.45999989875634E-10 |
| Normal-vs-ccB subtype |
6.24439999999948E-05 |
| ccA subtype-vs-ccB subtype |
3.782100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.2640999953214E-08 |
| Normal-vs-N1 |
2.46119999999239E-05 |
| N0-vs-N1 |
3.063200E-01 |
|
|
